COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

Israel will begin offering a fourth dose of COVID-19 vaccine

High risk patients such as people over 60, the immunocompromised and healthcare workers will soon be eligible for another shot.

Thumbnail

FDA authorizes Pfizer’s COVID-19 pill

Paxlovid becomes the first treatment for the coronavirus taken in pill form, the federal agency announced.

Thumbnail

Biden administration announces new actions to help hospitals keep up with omicron

The feds are making a large push to expand testing, setting up new sites across the U.S. and sending 500 million free kits to Americans beginning Jan. 1.

JPMorgan moves annual healthcare conference online following omicron concerns

Biotech giants Moderna and Amgen both recently dropped out of the in-person meeting, which was set to take place next month in San Francisco.

Thumbnail

Pfizer says its pill remains 89% effective against COVID-19 in final study results

The health giant also noted that the antiviral worked in lab studies against the omicron variant.

Assessing blood samples with new device pinpoints early warning signs for COVID-19 patients

The researchers found an unusually high amount of platelet aggregation in patient samples, a known indicator of microvascular thrombosis.

vaccine syringe covid-19 coronavirus

FDA expands Pfizer booster shots to 16- and 17-year-olds

The emergency authorization paves the way for millions of younger adults to get a third dose of the vaccine.

‘Potentially big impact’: New ingredient praised as possible solution for better COVID-19 vaccines

Early experiments showed the saponin/TLR adjuvant activates many different parts of the immune system to strengthen its response against invading pathogens.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”